Skip to content
OpenCapital
Get started

Gilead Sciences GILD Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Incyte logo
IncyteINCY
$15.31B+55.9%
Merck & Co. logo
Merck & Co.MRK
$341.11B+34.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
ALN
Alnylam PharmaceuticalsALNY
$42.43B+24.1%
Biogen logo
BiogenBIIB
$30.08B+34.9%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$155.75B+23.8%
P/E16.9×-4.2×
P/S5.2×+0.9×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio2×+0.6×

Where this comes from

Calculated from Gilead Sciences’s reported figures.

$172.99Bmarket cap+$22.2Btotal debt−$7.6Bcash and equivalents=$187.53B

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's enterprise value?
Gilead Sciences (GILD) reported enterprise value of $187.53B in Q1 2026.
How has Gilead Sciences's enterprise value changed year-over-year?
Gilead Sciences's enterprise value increased by 19.7% year-over-year, from $156.71B to $187.53B.
What is the long-term trend for Gilead Sciences's enterprise value?
Over 4 years (2021 to 2025), Gilead Sciences's enterprise value has grown at a 9.5% compound annual growth rate (CAGR), from $442.8B to $635.46B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.